文献速递食管与纵隔外科

胸腔镜手术治疗下行性坏死性纵隔炎疗效分析

The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

基于日本2012至2016年下行性坏死性纵隔炎数据库,比较电视辅助胸腔镜手术(VATS)与开胸行纵隔引流患者的预后。VATS组83例、开胸组58例,术后90天死亡率分别为4.8%和8.6%,校正风险差为-0.0077(95%CI -0.0959至0.0805,P=0.8649)。结论认为下行性坏死性纵隔炎的治疗结局不取决于开胸或VATS。

要点

  • VATS组与开胸组术后90天死亡率分别为4.8%和8.6%,校正风险差-0.0077(95%CI -0.0959至0.0805,P=0.8649)。
  • VATS组术后并发症发生率53.0%高于开胸组24.1%,再手术率37.9%高于开胸组15.5%。
  • 作者结论认为下行性坏死性纵隔炎的治疗结局不取决于开胸或VATS。

核心结论

  • 下行性坏死性纵隔炎的治疗结局不取决于采用开胸还是VATS。

研究设计与样本

  • 利用日本胸外科学会与日本支气管食管学会构建的2012年至2016年下行性坏死性纵隔炎数据库,分析经VATS或开胸行纵隔引流的患者。
  • 主要结局为90天死亡率,采用纳入倾向性评分的回归模型估计VATS组与开胸组之间的校正风险差。

主要发现

  • VATS组83例,开胸组58例。
  • 一般状况较差的患者常接受VATS,感染延伸至前、后下纵隔的患者常接受开胸。
  • 术后90天死亡率VATS组4.8% vs 开胸组8.6%,校正风险差-0.0077(95%CI -0.0959至0.0805,P=0.8649)。
  • 术后30天和1年死亡率两组间未发现临床和统计学差异。
  • 术后并发症发生率VATS组53.0% vs 开胸组24.1%,再手术率VATS组37.9% vs 开胸组15.5%,并发症不严重,多数可通过再手术和重症监护处理。

临床怎么用

  • 原文未据此给出推荐,仅结论认为下行性坏死性纵隔炎的治疗结局不取决于开胸或VATS。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Thoracotomy is a reliable approach for descending necrotizing mediastinitis (DNM), and the use of video-assisted thoracic surgery (VATS), a minimally invasive procedure, has been increasing. However, which approach is more effective for DNM treatment is controversial. METHODS: We analysed patients who underwent mediastinal drainage via VATS or thoracotomy, using a database with DNM from 2012 to 2016 in Japan, which was constructed by the Japanese Association for Chest Surgery and the Japan Broncho-esophagological Society. The primary outcome was 90-day mortality, and the adjusted risk difference between the VATS and thoracotomy groups using a regression model, which incorporated the propensity score, was estimated. RESULTS: VATS was performed on 83 patients and thoracotomy on 58 patients. Patients with a poor performance status commonly underwent VATS. Meanwhile, patients with infection extending to both the anterior and posterior lower mediastinum frequently underwent thoracotomy. Although the postoperative 90-day mortality was different between the VATS and thoracotomy groups (4.8% vs 8.6%), the adjusted risk difference was almost the same, -0.0077 with 95% confidence interval of -0.0959 to 0.0805 (P = 0.8649). Moreover, we could not find any clinical and statistical differences between the 2 groups in terms of postoperative 30-day and 1-year mortality. Although patients who underwent VATS had higher postoperative complication (53.0% vs 24.1%) and reoperation (37.9% vs 15.5%) rates than those who underwent thoracotomy, the complications were not serious and most could be treated with reoperation and intensive care. CONCLUSIONS: The outcome of DNM treatment does not depend on thoracotomy or VATS.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tanaka Y, Maniwa Y, Sugio K, et al. The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37018143. doi:10.1093/icvts/ivad053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。